Filter Search


Europe


Location Summary Deadline
Germany Open House Drug Discount Agreements Flupentixol, Atc N05af01 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Elafibranor (obo), Atc A05ax06 For The Period 01.12.2024 30.11.2026 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Elafibranor (obo), Atc A05ax06 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Dihydrocodeine (obg), Atc R05da14 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Lithuania Purchase Of Vehicle Operating Leases 2026-10-05
Germany Open House Drug Rebate Agreements Bosutinib, Atc L01ea04 2026-10-05
Germany Open House Drug Discount Agreements Vildagliptin, Atc A10bh02 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Tobramycin (excl. Hard Capsules With Powder For Inhalation), (obo), Atc J01gb01 F. D. Z. 01.12.2430.11.26 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Guselkumab (exclusively In The Strength 100 Mg), (obo), Atc L04ac16 For The Period 01.12.2024 30.11.2026 2026-10-05
France Conclusion Of Non-exclusive Supply Agreements With The Possibility Of Conclusion At Any Time Within The Framework Of The So-called Open House Procedure 2026-10-05
Whats app